Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymic regulatory T cells.

Enrico Maggi1, Lorenzo Cosmi, Francesco Liotta

  • 1Center of Research, Transfer, High Education MCIDNENT, University of Florence, Firenze, Italy. e.maggi@dmi.unifi.it

Autoimmunity Reviews
|October 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of Prophylactic Anakinra in Patients Treated with CD28-Based CD19 Chimeric Antigen Receptor-T Cells for R/R B-Cell Lymphoma.

Transplantation and cellular therapy·2026
Same author

The transmembrane IL-15 isoform expressed on human melanoma cells triggers modulatory effects on tumor progression upon stimulation with the soluble IL-15Rα chain.

Frontiers in immunology·2026
Same author

APL-like subset within <i>NPM1</i>-mutated AML: A distinct immunophenotype correlating with early vascular complications.

HemaSphere·2026
Same author

Dupilumab in Chronic Rhinosinusitis With Nasal Polyps Patients: Impact on Tissue Eosinophilic Inflammation and Eosinophil Subphenotypes.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapy.

Frontiers in immunology·2026
Same author

Drug development in systemic sclerosis: novel therapeutics to watch.

Expert review of clinical immunology·2026

Regulatory T (Treg) cells, including CD4+CD25+ and CD8+CD25+ subsets found in human thymuses, prevent autoimmune reactions. These thymic Treg cells suppress Th1 immune responses, crucial for maintaining self-tolerance.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Regulatory T (Treg) cells are crucial for immune homeostasis and preventing autoimmunity.
  • Treg cells are broadly classified into natural (thymus-derived) and adaptive (periphery-derived) subsets.
  • Natural Treg cells develop in the thymus and are selected through TCR interactions with self-peptides.

Purpose of the Study:

  • To investigate the characteristics and function of newly identified CD4+CD25+ and CD8+CD25+ Treg cells in human thymuses.
  • To determine the suppressive capacity of these thymic Treg cells on other immune cells.

Main Methods:

  • Flow cytometry and molecular analysis to identify and characterize CD4+CD25+ and CD8+CD25+ thymocytes.
  • In vitro co-culture assays to assess the suppressive activity of Treg cells on autologous thymocytes and Th1/Th2 cells.

Related Experiment Videos

Main Results:

  • CD4+CD25+ and CD8+CD25+ human thymocytes express key Treg markers like Foxp3 and CTLA-4.
  • These thymic Treg cells suppress autologous CD4+CD25- thymocyte proliferation via cell-contact dependent mechanisms involving CTLA-4 and TGF-beta.
  • Thymic Treg cells exhibit potent suppression of Th1 cells but weaker suppression of Th2 cells.

Conclusions:

  • Human thymuses harbor CD4+CD25+ and CD8+CD25+ Treg cells with suppressive functions.
  • These thymic Treg cells play a vital role in maintaining self-tolerance and preventing autoimmune disorders, particularly by inhibiting Th1-mediated responses.